Effectiveness of 1.25 % povidone-iodine combined with topical levofloxacin against conjunctival flora in intravitreal injection

Japanese Journal of Ophthalmology

Volumn 56, Issue 5, 2012, Pages 497-501

  Ikuno, Yasushi ^a   Sawa, Miki ^a   Tsujikawa, Motokazu ^a   Gomi, Fumi ^a   Maeda, Naoyuki ^a   Nishida, Kohji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Endophthalmitis; Intravitreal injection; Levofloxacin; Povidine iodine

Indexed keywords

AMIKACIN; BETADYNE; BEVACIZUMAB; CEFTAZIDIME; CHLORAMPHENICOL; CLARITHROMYCIN; EYE DROPS; LEVOFLOXACIN; OXACILLIN; POVIDONE IODINE; RANIBIZUMAB; SULTAMICILLIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLUS; BACTERIAL FLORA; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BACTERIUM ISOLATE; COMBINATION CHEMOTHERAPY; CONJUNCTIVA; CONTROLLED STUDY; CORYNEBACTERIUM; DISINFECTION; DRUG EFFECT; DRUG EFFICACY; DRUG INSTILLATION; ENTEROCOCCUS; ENTEROCOCCUS DURANS; ENTEROCOCCUS FAECALIS; HUMAN; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; NEEDLE; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PROPIONIBACTERIUM GRANULOSUM; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STAPHYLOCOCCUS CAPITIS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS LUGDUNENSIS; STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS GORDONII; STREPTOCOCCUS ORALIS;

ANGIOGENESIS INHIBITORS; ANTI-INFECTIVE AGENTS, LOCAL; ANTIBODIES, MONOCLONAL, HUMANIZED; BACTERIA; CONJUNCTIVA; DISINFECTION; DRUG THERAPY, COMBINATION; ENDOPHTHALMITIS; HUMANS; INTRAVITREAL INJECTIONS; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; OPHTHALMIC SOLUTIONS; POVIDONE-IODINE; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 84866735288     PISSN: 00215155     EISSN: 16132246     Source Type: Journal    
DOI: 10.1007/s10384-012-0160-5     Document Type: Article

References (25)

1. Bressler NM. Antiangiogenic approaches to age-related macular degeneration today. Ophthalmology. 2009;116:S15-23.
2. Ciulla TA, Rosenfeld PJ. Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration. Curr Opin Ophthalmol. 2009;20:166-74.
3. Nicholson BP, Schachat AP. A review of clinical trials of anti-VEGF agents for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2010;248:915-30.
4. Cunningham ET Jr, Adamis AP, Altaweel M, Aiello LP, Bressler NM, D'Amico DJ, et al. Macugen Diabetic Retinopathy Study Group. A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology. 2005;112:1747-57.
5. Cohen SY. Anti-VEGF drugs as the 2009 first-line therapy for choroidal neovascularization in pathologic myopia. Retina. 2009; 29:1062-6.
6. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419-31.
7. Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T, et al. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology. 2009;116:57-65.
8. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1432-44.
9. Kaiser PK, Brown DM, Zhang K, Hudson HL, Holz FG, Shapiro H, et al. Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results. Am J Ophthalmol. 2007;144:850-7.
10. Mason JO 3rd, White MF, Feist RM, Thomley ML, Albert MA, Persaud TO, et al. Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection. Retina. 2008;28:564-7.
11. Pilli S, Kotsolis A, Spaide RF, Slakter J, Freund KB, Sorenson J, et al. Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting. Am J Ophthalmol. 2008;145:879-82.
12. Barry P, Gardner S, Seal D, Gettinby G, Lees F, Peterson M, et al. Clinical observations associated with proven and unproven cases in the ESCRS study of prophylaxis of postoperative endoph-thalmitis after cataract surgery. J Cataract Refract Surg. 2009;35: 1523-31.
13. Moss JM, Sanislo SR, Ta CN. A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections. Ophthalmology. 2009;116: 1498-501.
14. Ziemssen F, Bartz-Schmidt KU. Topical antibiotics to reduce the risk of endophthalmitis after intravitreal injection? Arch Oph-thalmol. 2010;128:1222-3.
15. Matsumoto M, Suzuma K, Miyamura N, Imamura N, Kitaoka T. Conjunctival swabs and corneoscleral rim cultures from corneal transplantation donors as possible early indicators for posttrans-plant endopthalmitis. Jpn J Ophthalmol. 2011;55:321-6.
16. Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology. 1991;98:1769-75.
17. Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology. 2002;109:13-24. (review).
18. Ta CN. Minimizing the risk of endophthalmitis following intra-vitreous injections. Retina. 2004;24:699-705. (review).
19. Berkelman RL, Holland BW, Anderson RL. Increased bacterial activity of dilute preparations of povidone-iodine solutions. J Clin Microbiol. 1982;15:635-9.
20. Shimada H, Arai S, Nakashizuka H, Hattori T, Yuzawa M. Reduction of anterior chamber contamination rate after cataract surgery by intraoperative surface irrigation with 0.25 % povi-done-iodine. Ophthalmology. 2011;151:11-7.
21. Isenberg SJ, Apt L, Yoshimori R, Khwarg S. Chemical preparation of the eye in ophthalmic surgery. IV. Comparison of povidone-iodine on the conjunctiva with a prophylactic antibiotic. Arch Ophthalmol. 1985;103:1340-2.
22. Inoue Y, Usui M, Ohashi Y, Shiota H, Yamazaki T, Preoperative Disinfection Study Group. Preoperative disinfection of the con-junctival sac with antibiotics and iodine compounds: a prospective randomized multicenter study. Jpn J Ophthalmol. 2008;52: 151-61.
23. Lemley CA, Han DP. Endophthalmitis: a review of current evaluation and management. Retina. 2007;27:662-80.
24. de Caro JJ, Ta CN, Ho HK, Cabael L, Hu N, Sanislo SR, et al. Bacterial contamination of ocular surface and needles in patients undergoing intravitreal injections. Retina. 2008;28:877-83.
25. Nentwich M, Yactayo-Miranda Y, Weimann S, Froehlich S, Wolf A, Kampik A, et al. Bacterial contamination of needle points after intravitreal injection. Eur J Ophthalmol. 2009;19:268-72.